287 related articles for article (PubMed ID: 24423979)
1. Growth hormone, insulin-like growth factor-1, and the kidney: pathophysiological and clinical implications.
Kamenický P; Mazziotti G; Lombès M; Giustina A; Chanson P
Endocr Rev; 2014 Apr; 35(2):234-81. PubMed ID: 24423979
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic effects of growth hormone on renal regulation of electrolyte and water homeostasis.
Dimke H; Flyvbjerg A; Frische S
Growth Horm IGF Res; 2007 Oct; 17(5):353-68. PubMed ID: 17560155
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone, the insulin-like growth factor system, and the kidney.
Feld S; Hirschberg R
Endocr Rev; 1996 Oct; 17(5):423-80. PubMed ID: 8897021
[TBL] [Abstract][Full Text] [Related]
4. Role of growth hormone in chronic heart failure: therapeutic implications.
Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
[TBL] [Abstract][Full Text] [Related]
5. The physiological and pathophysiological roles of the GH/IGF-axis in the kidney: lessons from experimental rodent models.
Cingel-Ristić V; Flyvbjerg A; Drop SL
Growth Horm IGF Res; 2004 Dec; 14(6):418-30. PubMed ID: 15519249
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone axis in chronic kidney disease.
Mahesh S; Kaskel F
Pediatr Nephrol; 2008 Jan; 23(1):41-8. PubMed ID: 17676425
[TBL] [Abstract][Full Text] [Related]
7. The GH-IGF-I axis and the cardiovascular system: clinical implications.
Colao A
Clin Endocrinol (Oxf); 2008 Sep; 69(3):347-58. PubMed ID: 18462260
[TBL] [Abstract][Full Text] [Related]
8. Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes.
Flyvbjerg A
Kidney Int Suppl; 1997 Sep; 60():S12-9. PubMed ID: 9285896
[TBL] [Abstract][Full Text] [Related]
9. Impact of growth hormone hypersecretion on the adult human kidney.
Grunenwald S; Tack I; Chauveau D; Bennet A; Caron P
Ann Endocrinol (Paris); 2011 Dec; 72(6):485-95. PubMed ID: 22098791
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of growth hormone in health and in kidney disease.
Haffner D; Grund A; Leifheit-Nestler M
Pediatr Nephrol; 2021 Aug; 36(8):2511-2530. PubMed ID: 34143299
[TBL] [Abstract][Full Text] [Related]
11. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
Gravholt CH; Naeraa RW; Fisker S; Christiansen JS
J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
[TBL] [Abstract][Full Text] [Related]
12. Derangements of the somatotropic hormone axis in chronic renal failure.
Tönshoff B; Blum WF; Mehls O
Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957
[TBL] [Abstract][Full Text] [Related]
13. New concepts: growth hormone, insulin-like growth factor-I and the kidney.
Rabkin R; Schaefer F
Growth Horm IGF Res; 2004 Aug; 14(4):270-6. PubMed ID: 15231295
[TBL] [Abstract][Full Text] [Related]
14. The growth hormone and insulin-like growth factor axis: its manipulation for the benefit of growth disorders in renal failure.
Roelfsema V; Clark RG
J Am Soc Nephrol; 2001 Jun; 12(6):1297-1306. PubMed ID: 11373355
[TBL] [Abstract][Full Text] [Related]
15. Liver-derived IGF-I regulates kidney size, sodium reabsorption, and renal IGF-II expression.
Svensson J; Tivesten A; Sjögren K; Isaksson O; Bergström G; Mohan S; Mölne J; Isgaard J; Ohlsson C
J Endocrinol; 2007 Jun; 193(3):359-66. PubMed ID: 17535874
[TBL] [Abstract][Full Text] [Related]
16. Somatopause reflects age-related changes in the neural control of GH/IGF-I axis.
Giordano R; Lanfranco F; Bo M; Pellegrino M; Picu A; Baldi M; Balbo M; Bonelli L; Grottoli S; Ghigo E; Arvat E
J Endocrinol Invest; 2005; 28(3 Suppl):94-8. PubMed ID: 16042366
[TBL] [Abstract][Full Text] [Related]
17. Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults.
Bianda T; Glatz Y; Bouillon R; Froesch ER; Schmid C
J Clin Endocrinol Metab; 1998 Jan; 83(1):81-7. PubMed ID: 9435420
[TBL] [Abstract][Full Text] [Related]
18. Comparison of pancreas-transplanted type 1 diabetic patients with portal-venous versus systemic-venous graft drainage: impact on glucose regulatory hormones and the growth hormone/insulin-like growth factor-I axis.
Frystyk J; Ritzel RA; Maubach J; Büsing M; Lück R; Klempnauer J; Schmiegel W; Nauck MA
J Clin Endocrinol Metab; 2008 May; 93(5):1758-66. PubMed ID: 18319317
[TBL] [Abstract][Full Text] [Related]
19. The GH/IGF-1 axis in chronic heart failure.
Arcopinto M; Bobbio E; Bossone E; Perrone-Filardi P; Napoli R; Sacca L; Cittadini A
Endocr Metab Immune Disord Drug Targets; 2013 Mar; 13(1):76-91. PubMed ID: 23369140
[TBL] [Abstract][Full Text] [Related]
20. The growth hormone-insulin-like growth factor axis in kidney.
Hammerman MR
Am J Physiol; 1989 Oct; 257(4 Pt 2):F503-14. PubMed ID: 2679142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
